Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Evaluation of the Impact of Self-rehabilitation After Foot Surgery Via a Connected Application

NCT07653828 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2021-06-28
Last updated
2026-07-16

Condition(s) studied

Hallux Valgus

Investigational drug(s) / intervention(s)

Hallux valgus surgeryQuestionnairesPhysiotheray sessions

Hallux valgus surgery: Primary surgery for hallux valgus

Questionnaires: Different questionnaires : EFAS, EVA, EQ-5DL

Physiotheray sessions: Physiotherapy sessions twice a week for 10 weeks.

Study summary

Hallux valgus is the most common forefoot deformity and primarily affects women. Surgical treatment involves an osteotomy of the first metatarsal to reduce the M1-M2 angle. Often, an osteotomy of the first phalanx of the big toe is performed in conjunction to reduce the M1-P1 angle.

Once the deformity has been corrected, the second objective is to restore the foot's function, particularly mobility and plantar flexion strength. To achieve this, rehabilitation is prescribed, but inconsistently due to the lack of clear guidelines and limited patient participation, especially outside of the physiotherapist's scheduled appointments.

Continuous passive range of motion exercises can accelerate the return to standard footwear and normal joint mobility. This study is based on the hypothesis that an application connected with rehabilitation exercises to be done outside of sessions with a physiotherapist reproduces this mechanism of continuous passive mobility. In this context, it is hoped that patients benefiting from self-rehabilitation of the foot via the connected application, in addition to traditional care with a physiotherapist, will achieve better postoperative mobility of the metatarsophalangeal joint of the hallux compared to traditional care with a physiotherapist in patients undergoing hallux valgus surgery, with an isolated procedure on the first ray.

The main objective is to compare the mobility of the metatarsophalangeal joint of the hallux 6 months after an operation for isolated hallux valgus by osteotomy in patients benefiting from optimized rehabilitation with a physiotherapist using a connected application compared to patients receiving standard care with a physiotherapist.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Age \> 18 years and \< 85 years, * Patient, male or female, undergoing surgery for unilateral and isolated Hallux valgus with procedure of the 1st ray, * First-line surgery, * Persistent mobility of the metatarsophalangeal joint of the hallux, * Patient in possession of a smartphone or tablet, * Patient affiliated with or beneficiary of a social security scheme, * Patient who has signed the free and informed consent. Exclusion Criteria: * Patient not having a smartphone or tablet, * Rheumatoid foot, * Hallux rigidus/MTP1 osteoarthritis, * Gestures on the lateral rays * Surgical or traumatic history influencing MTP1 mobility. * Minors * Adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial decision or administrative; * Pregnant, breastfeeding or parturient woman; - Hospitalized without consent

Primary outcome measure(s)

  • Mobility of the metatarsophalangeal joint of the hallux — 6 months
    Mobility of the metatarsophalangeal joint of the hallux is measured by the MTP1 angle (FD + FP), which will be clinically assessed using a goniometer.

Trial sites (1)

FacilityCityRegionStatus
Clinique de l'Union Saint-Jean France Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07653828 on ClinicalTrials.gov ↗ ← All trials in France